T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.87% |
| 2 | Financials | 13.64% |
| 3 | Consumer Discretionary | 13.54% |
| 4 | Industrials | 10.67% |
| 5 | Technology | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Semtech
SMTC
$12.4B
| $133M | 0.03% |
6,714,350
+1,391,480
| +26% | +$32.4M |
|
|
ESRX
527
DELISTED
Express Scripts Holding Company
ESRX
| $133M | 0.03% |
1,498,417
-25,340
| -2% | -$2.21M |
|
528
Westamerica Bancorp
WABC
$1.39B
| $133M | 0.03% |
2,620,478
-3,140
| -0.1% | -$144K |
|
529
Host Hotels & Resorts
HST
$15.6B
| $132M | 0.03% |
6,670,675
+3,157
| +0% | +$63.6K |
|
|
TRNX
530
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $132M | 0.03% |
5,287,579
+65,200
| +1% | +$1.7M |
|
|
SGEN
531
DELISTED
Seagen Inc. Common Stock
SGEN
| $132M | 0.03% |
2,720,256
+30,684
| +1% | +$1.27M |
|
532
Adtran
ADTN
$658M
| $132M | 0.03% |
8,093,748
-210,450
| -3% | -$3.61M |
|
|
WRI
533
DELISTED
Weingarten Realty Investors
WRI
| $131M | 0.03% |
4,017,323
-97,439
| -2% | -$3.3M |
|
534
Expeditors International
EXPD
$24.3B
| $130M | 0.03% |
2,822,135
-943,898
| -25% | -$44.4M |
|
535
Encompass Health
EHC
$12.2B
| $130M | 0.03% |
3,540,196
+39,985
| +1% | +$1.43M |
|
|
EMC
536
DELISTED
EMC CORPORATION
EMC
| $129M | 0.03% |
4,902,102
-809,357
| -14% | -$21.6M |
|
537
Clearwater Paper
CLW
$354M
| $126M | 0.03% |
2,206,210
-447,496
| -17% | -$27.6M |
|
538
RB Global
RBA
$16B
| $126M | 0.03% |
4,527,285
+1,986,735
| +78% | +$54.5M |
|
|
CIT
539
DELISTED
CIT Group Inc.
CIT
| $126M | 0.03% |
2,710,540
-211,442
| -7% | -$9.84M |
|
540
Cameco
CCJ
$42.6B
| $126M | 0.03% |
8,823,860
+451,290
| +5% | +$7.13M |
|
|
HR
541
DELISTED
Healthcare Realty Trust Incorporated
HR
| $125M | 0.03% |
5,375,710
+249,170
| +5% | +$6.24M |
|
|
EE
542
DELISTED
El Paso Electric Company
EE
| $125M | 0.03% |
3,594,213
+12,540
| +0.4% | +$457K |
|
543
A.O. Smith
AOS
$8.49B
| $124M | 0.03% |
3,455,860
-873,100
| -20% | -$30.1M |
|
544
ScottsMiracle-Gro
SMG
$3.59B
| $124M | 0.03% |
2,091,039
-246,390
| -11% | -$15.6M |
|
|
DCT
545
DELISTED
DCT Industrial Trust Inc.
DCT
| $122M | 0.03% |
3,893,994
+62,395
| +2% | +$2.08M |
|
546
ESCO Technologies
ESE
$7.79B
| $122M | 0.03% |
3,272,340
-14,690
| -0.4% | -$555K |
|
|
DYAX
547
DELISTED
DYAX CORPORATION
DYAX
| $122M | 0.03% |
4,612,666
+339,540
| +8% | +$9M |
|
548
Target
TGT
$70.6B
| $122M | 0.03% |
1,495,314
+7,430
| +0.5% | +$601K |
|
549
Infosys
INFY
$50.3B
| $121M | 0.02% |
15,265,084
+13,844,096
| +974% | +$112M |
|
550
Ultragenyx Pharmaceutical
RARE
$2.6B
| $121M | 0.02% |
1,179,140
-66,700
| -5% | -$5.18M |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.